Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Gyre Therapeutics, Inc. (GYRE)
US NASDAQ Healthcare Biotechnology
Address
12770 High Bluff Drive 92130
San Diego, CA, US
San Diego, CA, US
CEO
Ping Zhang
Website
gyretx.com
IPO
2006-04-12
CIK 1124105 ISIN US4037831033
Description
Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs. The company's key anti-fibrotic medication, ETUARY (Pirfenidone), has received approval for treating idiopathic pulmonary fibrosis. Beyond this, ETUARY is also undergoing late-stage (Phase 3) clinical trials for several other conditions, including dermatomyositis and interstitial lung disease linked to systemic sclerosis, pneumoconiosis, and diabetic kidney disease. The company's pipeline further includes F351 (Hydronidone), a compound structurally related to ETUARY. F351 is currently in Phase 3 studies for chronic hepatitis B-induced liver fibrosis and is in Phase 1 trials for liver fibrosis associated with nonalcoholic associated steatohepatitis (NASH). Other programs in development feature F573, which is progressing through Phase 2 studies for acute and acute-on-chronic liver failure. Additionally, two early-stage candidates, F528 and F230, are in preclinical development, focusing on chronic obstructive pulmonary disease (COPD) and pulmonary arterial hypertension (PAH), respectively. Established in 2002, Gyre Therapeutics, Inc. is based in San Diego, California, and operates as a subsidiary of GNI USA, Inc.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
91.6K
Beta
4.78
Float Shares
17.32M
Free Float %
17.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.96% | -7.59% | -1.22% | -6.65% | -12.47% | +3.40% | -32.59% | +121.21% | -88.73% | -97.75% | -99.95% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
7.02
Low
16.00
+128.1%
Consensus
17.00
+142.3%
Median
17.00
+142.3%
High
18.00
+156.6%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 2 |
17.00
|
| All Time | 2 |
17.00
|
Quality scores
Altman Z-Score
17.57
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+10.2% ★ Q1'26: +2.1% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-55.0% Q1'26: -2,425.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-6.3% Q1'26: +13.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+9.9% ★ Q1'26: -41.5% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+8.7% ★ Q1'26: -34.8% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+0.9% ★ Q1'26: -10.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.07× ★ Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
399.0K
est: 432.0K (-7.6%)
|
1.02M
est: 811.0K (+25.5%)
|
6.0K
est: 528.0K (-98.9%)
|
—
est: 15.00M (-100.0%)
|
20.95M
est: 18.97M (+10.4%)
|
7.34M
est: 5.07M (+44.8%)
|
102.29M
est: 1.00M (+10,129.0%)
|
113.45M
est: 113.45M (+0.0%)
|
105.76M
est: 101.39M (+4.3%)
|
116.59M
est: 114.83M (+1.5%)
|
135.33M
117.57M – 160.46M
+17.9% YoY
|
130.75M
113.59M – 155.02M
-3.4% YoY
|
433.50M
431.65M – 435.35M
+231.5% YoY
|
262.30M
227.87M – 311.00M
-39.5% YoY
|
306.50M
266.27M – 363.40M
+16.9% YoY
|
| EBITDA |
-16.95M
est: -134.0K (-12,542.1%)
|
-21.82M
est: -251.6K (-8,572.3%)
|
-33.82M
est: -163.8K (-20,545.6%)
|
-55.03M
est: -4.65M (-1,082.5%)
|
-56.10M
est: -5.89M (-853.1%)
|
-87.64M
est: -1.57M (-5,475.1%)
|
10.33M
est: -310.3K (+3,430.0%)
|
20.33M
est: -35.20M (+157.7%)
|
17.82M
est: -8.74M (+303.8%)
|
14.01M
est: -9.90M (+241.5%)
|
-11.67M
-13.84M – -10.14M
-17.9% YoY
|
-11.28M
-13.37M – -9.80M
+3.4% YoY
|
-37.38M
-37.54M – -37.22M
-231.5% YoY
|
-22.62M
-26.82M – -19.65M
+39.5% YoY
|
-26.43M
-31.34M – -22.96M
-16.9% YoY
|
| EBIT |
-16.95M
est: -137.1K (-12,256.3%)
|
-21.56M
est: -257.4K (-8,274.9%)
|
-30.06M
est: -167.6K (-17,831.5%)
|
-55.18M
est: -4.76M (-1,058.8%)
|
-56.24M
est: -6.02M (-833.8%)
|
-87.93M
est: -1.61M (-5,367.2%)
|
9.20M
est: -317.4K (+2,999.1%)
|
19.21M
est: -36.01M (+153.3%)
|
16.23M
est: -9.91M (+263.8%)
|
11.49M
est: -11.22M (+202.4%)
|
-13.23M
-15.68M – -11.49M
-17.9% YoY
|
-12.78M
-15.15M – -11.10M
+3.4% YoY
|
-42.37M
-42.55M – -42.19M
-231.5% YoY
|
-25.64M
-30.39M – -22.27M
+39.5% YoY
|
-29.95M
-35.52M – -26.02M
-16.9% YoY
|
| Net Income |
-16.95M
est: -34.87B (+100.0%)
|
-21.56M
est: -12.13B (+99.8%)
|
-30.06M
est: -3.86B (+99.2%)
|
-55.18M
est: -5.05B (+98.9%)
|
-55.54M
est: -4.14B (+98.7%)
|
-87.93M
est: -4.31B (+98.0%)
|
2.30M
est: 1.41B (-99.8%)
|
-92.93M
est: -245.50M (+62.1%)
|
12.09M
est: 17.54M (-31.1%)
|
5.03M
est: 16.85M (-70.2%)
|
-26.70M
-35.86M – -23.96M
-258.4% YoY
|
-10.68M
-12.81M – -8.56M
+60.0% YoY
|
187.00M
161.73M – 242.08M
+1,850.4% YoY
|
26.83M
22.25M – 33.30M
-85.7% YoY
|
35.08M
29.09M – 43.55M
+30.8% YoY
|
| SGA |
9.26M
est: 466.7K (+1,884.6%)
|
9.99M
est: 876.1K (+1,040.6%)
|
12.35M
est: 570.4K (+2,065.8%)
|
13.27M
est: 16.20M (-18.1%)
|
16.18M
est: 20.50M (-21.1%)
|
18.82M
est: 5.47M (+243.8%)
|
71.61M
est: 1.08M (+6,528.4%)
|
75.82M
est: 122.56M (-38.1%)
|
73.62M
est: 108.82M (-32.3%)
|
85.98M
est: 123.26M (-30.2%)
|
145.26M
126.19M – 172.23M
+17.9% YoY
|
140.34M
121.92M – 166.39M
-3.4% YoY
|
465.29M
463.31M – 467.28M
+231.5% YoY
|
281.54M
244.58M – 333.81M
-39.5% YoY
|
328.98M
285.80M – 390.06M
+16.9% YoY
|
| EPS |
-21.76
est: -340.88 (+93.6%)
|
-6.30
est: -118.60 (+94.7%)
|
-2.68
est: -37.73 (+92.9%)
|
-4.41
est: -49.35 (+91.1%)
|
-2.93
est: -40.46 (+92.8%)
|
-2.87
est: -42.11 (+93.2%)
|
0.03
est: 13.80 (-99.8%)
|
-1.41
est: -2.40 (+41.3%)
|
0.14
est: 0.17 (-17.6%)
|
0.06
est: 0.16 (-65.5%)
|
-0.28
-0.35 – -0.23
-271.4% YoY
|
-0.10
-0.12 – -0.08
+64.3% YoY
|
1.89
1.57 – 2.35
+1,990.0% YoY
|
0.26
0.22 – 0.32
-86.2% YoY
|
0.34
0.28 – 0.42
+30.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.42M
OE per share TTM
0.05
Owner's Yield
0.22%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
21.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
10
Total invested
1.39M
Insider transactions (90d)
6
Beneficial owners (>5%)
4
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ping Lan | 8.46M | 8.54% | — | 8.46M | — | 10.00 | IN | — | 2024-09-06 | ↗ |
| 2 | Ying Luo (“Mr. Luo”) | 8.46M | 8.54% | — | 8.46M | — | 10.00 | IN | — | 2024-09-06 | ↗ |
| 3 | Songjiang Ma (“Mr. Ma”) | 7.46M | 7.62% | — | 7.46M | — | 7.46M | IN | — | 2024-09-06 | ↗ |
| 4 | Yueying Zhu | 7.46M | 7.62% | — | 7.46M | — | 7.46M | IN | — | 2024-09-06 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
10
-33 vs prev Q
New positions
3
Closed positions
36
Increased
4
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1.20M +51.0K (+4.4%) | 8.48M -100.0K (-1.2%) | 1.35% +0.057 pp | 0.00% +0.000 pp | USD10.98 -35.7% | 9 qtrs — |
| 2 | BLACKROCK, INC. | 720.3K +60.9K (+9.2%) | 5.09M +166.2K (+3.4%) | 0.81% +0.068 pp | 0.00% +0.000 pp | USD10.32 -31.6% | 6 qtrs — |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 423.2K +48.6K (+13.0%) | 2.99M +193.7K (+6.9%) | 0.47% +0.055 pp | 0.00% +0.000 pp | USD14.78 -52.2% | 9 qtrs — |
| 4 | STATE STREET CORP | 202.2K +19.5K (+10.7%) | 1.43M +64.4K (+4.7%) | 0.23% +0.022 pp | 0.00% +0.000 pp | USD11.75 -39.9% | 9 qtrs — |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 169.2K +45.8K (+37.1%) | 1.19M +273.8K (+29.7%) | 0.19% +0.051 pp | 0.00% +0.000 pp | USD10.47 -32.6% | 7 qtrs — |
| 6 | SBI SECURITIES CO., LTD. | 162.9K -5.0K (-2.9%) | 1.15M -102.1K (-8.2%) | 0.18% -0.006 pp | 0.03% -0.003 pp | USD9.46 -25.4% | 5 qtrs — |
| 7 | NORTHERN TRUST CORP | 128.9K +12.5K (+10.8%) | 909.7K +41.8K (+4.8%) | 0.14% +0.014 pp | 0.00% +0.000 pp | USD12.66 -44.2% | 9 qtrs — |
| 8 | MORGAN STANLEY | 54.5K +45.5K (+506.8%) | 384.8K +317.8K (+474.3%) | 0.06% +0.051 pp | 0.00% +0.000 pp | USD7.51 -6.0% | 8 qtrs — |
| 9 | BANK OF NEW YORK MELLON CORP | 41.2K +16.8K (+68.9%) | 290.9K +108.9K (+59.8%) | 0.05% +0.019 pp | 0.00% +0.000 pp | USD8.84 -20.1% | 7 qtrs — |
| 10 | GOLDMAN SACHS GROUP INC | 31.1K +13.1K (+72.5%) | 219.6K +85.1K (+63.2%) | 0.03% +0.015 pp | 0.00% +0.000 pp | USD7.29 -3.2% | 8 qtrs — |
| 11 | STATE OF WISCONSIN INVESTMENT BOARD | 24.8K -14.2K (-36.4%) | 175.1K -115.9K (-39.8%) | 0.03% -0.016 pp | 0.00% 0.000 pp | USD7.35 -3.9% | 3 qtrs — |
| 12 | ALLIANCEBERNSTEIN L.P. | 21.8K +— (+0.0%) | 154.1K -8.7K (-5.4%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD7.36 -4.1% | 3 qtrs — |
| 13 | STRS OHIO | 21.1K +— (+0.0%) | 149.0K -8.4K (-5.4%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD7.39 -4.5% | 3 qtrs — |
| 14 | BARCLAYS PLC | 18.5K +9.2K (+99.5%) | 130.8K +14.4K (+12.3%) | 0.02% +0.010 pp | 0.00% +0.000 pp | USD8.09 -12.7% | 7 qtrs — |
| 15 | RHUMBLINE ADVISERS | 14.0K +600.0 (+4.5%) | 99.1K -1.1K (-1.1%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD10.25 -31.1% | 7 qtrs — |
| 16 | WELLS FARGO & COMPANY/MN | 12.9K +7.4K (+132.4%) | 91.2K +49.7K (+120.0%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD8.43 -16.3% | 9 qtrs — |
| 17 | ROYAL BANK OF CANADA | 12.8K +370.0 (+3.0%) | 91.0K -1.0K (-1.1%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD7.54 -6.4% | 7 qtrs — |
| 18 | DIMENSIONAL FUND ADVISORS LP | 10.9K +10.9K (+100.0%) | 77.0K +77.0K (+100.0%) | 0.01% +0.012 pp | 0.00% +0.000 pp | USD7.06 +0.0% | 1 qtrs NEW |
| 19 | DEUTSCHE BANK AG\ | 10.6K -314.0 (-2.9%) | 74.9K -6.6K (-8.1%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD7.35 -3.9% | 3 qtrs — |
| 20 | FMR LLC | 10.3K +100.0 (+1.0%) | 72.7K -3.4K (-4.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD7.52 -6.1% | 6 qtrs — |
| 21 | JANE STREET GROUP, LLC | 10.0K +10.0K (+100.0%) | 70.6K +70.6K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD7.06 +0.0% | 1 qtrs NEW |
| 22 | BANK OF AMERICA CORP /DE/ | 9.8K +3.1K (+45.9%) | 68.9K +19.0K (+38.1%) | 0.01% +0.003 pp | 0.00% +0.000 pp | USD9.61 -26.5% | 7 qtrs — |
| 23 | UBS GROUP AG | 9.6K -13.4K (-58.3%) | 67.7K -103.6K (-60.5%) | 0.01% -0.015 pp | 0.00% +0.000 pp | USD9.21 -23.3% | 9 qtrs — |
| 24 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 5.5K +1.3K (+30.4%) | 38.7K +7.3K (+23.4%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD9.44 -25.2% | 6 qtrs — |
| 25 | JPMORGAN CHASE & CO | 5.1K +1.4K (+38.4%) | 36.1K +8.5K (+31.0%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD10.31 -31.5% | 9 qtrs — |
| 26 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 5.2K +— (+0.0%) | 36.0K -2.0K (-5.3%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD7.46 -5.4% | 2 qtrs — |
| 27 | NEW YORK STATE COMMON RETIREMENT FUND | 2.7K +— (+0.0%) | 19.1K -1.1K (-5.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD12.04 -41.4% | 7 qtrs — |
| 28 | BNP PARIBAS ARBITRAGE, SNC | 2.6K +388.0 (+17.9%) | 18.0K +1.9K (+11.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD8.52 -17.1% | 8 qtrs — |
| 29 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 2.1K +— (+0.0%) | 14.8K -839.0 (-5.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.72 -8.5% | 4 qtrs — |
| 30 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.1K -617.0 (-22.9%) | 14.7K -5.4K (-27.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD9.56 -26.2% | 9 qtrs — |
| 31 | RUSSELL INVESTMENTS GROUP, LTD. | 2.0K +879.0 (+78.2%) | 14.1K +5.8K (+68.6%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD7.28 -3.0% | 2 qtrs — |
| 32 | LEGAL & GENERAL GROUP PLC | 1.4K +545.0 (+63.4%) | 9.9K +3.5K (+53.7%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD8.38 -15.8% | 7 qtrs — |
| 33 | SIMPLEX TRADING, LLC | 839.00 +675.0 (+411.6%) | 5.9K +4.9K (+492.3%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD7.14 -1.1% | 2 qtrs — |
| 34 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 726.00 -122.0 (-14.4%) | 5.1K -1.2K (-19.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD10.14 -30.4% | 7 qtrs — |
| 35 | AMERITAS INVESTMENT PARTNERS, INC. | 683.00 +— (+0.0%) | 4.8K -273.0 (-5.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD12.04 -41.4% | 7 qtrs — |
| 36 | ACTIVEST WEALTH MANAGEMENT | 533.00 +— (+0.0%) | 3.8K -213.0 (-5.4%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD12.04 -41.4% | 7 qtrs — |
| 37 | AMALGAMATED BANK | 371.00 +130.0 (+53.9%) | 3.0K +1.0K (+50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD10.29 -31.4% | 7 qtrs — |
| 38 | CITIGROUP INC | 268.00 -116.0 (-30.2%) | 1.9K -972.0 (-33.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD13.83 -49.0% | 9 qtrs — |
| 39 | OPTIVER HOLDING B.V. | 222.00 +— (+0.0%) | 1.6K -89.0 (-5.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.46 -5.4% | 2 qtrs — |
| 40 | NISA INVESTMENT ADVISORS, LLC | 102.00 +— (+0.0%) | 720.00 -41.0 (-5.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD10.37 -31.9% | 6 qtrs — |
| 41 | STERLING CAPITAL MANAGEMENT LLC | 59.00 +37.0 (+168.2%) | 417.00 +253.0 (+154.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD8.93 -20.9% | 6 qtrs — |
| 42 | ADVISOR GROUP HOLDINGS, INC. | 38.00 +— (+0.0%) | 268.00 -15.0 (-5.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD8.76 -19.4% | 9 qtrs — |
| 43 | SMARTLEAF ASSET MANAGEMENT LLC | 6.00 +6.0 (+100.0%) | 42.00 +42.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.00 +0.9% | 1 qtrs NEW |
| 44 | PRINCIPAL SECURITIES, INC. | — -85.0 (-100.0%) | — -634.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 45 | SRS CAPITAL ADVISORS, INC. | — -57.0 (-100.0%) | — -426.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 46 | LAZARD ASSET MANAGEMENT LLC | — -14.9K (-100.0%) | — -111.4K (-100.0%) | 0.00% -0.017 pp | 0.00% 0.000 pp | USD— | 4 qtrs SOLD |
| 47 | MILLENNIUM MANAGEMENT LLC | — -35.8K (-100.0%) | — -266.7K (-100.0%) | 0.00% -0.040 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 48 | ADVISORY SERVICES NETWORK, LLC | — -66.0 (-100.0%) | — -492.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 43 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree U.S. SmallCap Fund EES | 0.02% | 148.5K | 0.38% |
| 2 | iShares Russell 2000 Growth ETF IWO | 0.01% | 789.2K | 0.24% |
| 3 | Vanguard Russell 2000 Growth ETF VTWG | 0.00% | 64.9K | 0.06% |
| 4 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.00% | 12.2K | 0.25% |
| 5 | Global X - Russell 2000 ETF RSSL | 0.00% | 56.0K | 0.08% |
| 6 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.00% | 107.4K | 0.30% |
| 7 | iShares Russell 2000 BuyWrite ETF IWMW | 0.00% | 1.8K | 0.39% |
| 8 | iShares Russell 2000 ETF IWM | 0.00% | 2.62M | 0.19% |
| 9 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.00% | 17.1K | 0.36% |
| 10 | Schwab U.S. Small-Cap ETF SCHA | 0.00% | 649.6K | 0.03% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
9
Sells
0
Shares acquired
3.01M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+3,010,583
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | Xiong Yue | Officer | — | — | Series B Preferred Stock | 2,376,500 | 0.00 | — | 0 | D | ↗ |
| 2026-05-04 | Wang Jialiang (NMN) | Officer | — | — | Stock Option (Right to Buy) | 42,777 | 2.00 | 85.6K | 0 | D | ↗ |
| 2026-05-04 | Luo Ying | Director / Officer | — | — | Stock Option (Right to Buy) | 988,624 | 2.00 | 1.98M | 0 | D | ↗ |
| 2026-05-04 | GNI Group Ltd. | 10% Owner | J-Other | A | Series B Preferred Stock | 458,120 | 0.00 | — | 458,120 | I | ↗ |
| 2026-05-04 | Eastling Thomas Wilson | Officer | A-Award | A | Stock Option (Right to Buy) | 11,882 | 2.00 | 23.8K | 11,882 | D | ↗ |
| 2026-05-04 | Bergmann Joshua Benjamin | Officer | — | — | Stock Option (Right to Buy) | 47,530 | 8.09 | 384.5K | 0 | D | ↗ |
| 2026-01-07 | Zhang Ping | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 7.31 | 731.0K | 100,000 | D | ↗ |
| 2026-01-07 | Chen Ruoyu | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 7.31 | 365.5K | 50,000 | D | ↗ |
| 2025-08-18 | Weng Dan | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-08-05 | Zhang Ping | Director | A-Award | A | Stock Option (Right to Buy) | 250,000 | 6.92 | 1.73M | 250,000 | D | ↗ |
| 2025-06-04 | Parry Renate | Director | A-Award | A | Stock Option (Right to Buy) | 26,000 | 8.58 | 223.1K | 26,000 | D | ↗ |
| 2025-06-04 | Nussbaum Rodney L | Director | A-Award | A | Stock Option (Right to Buy) | 26,000 | 8.58 | 223.1K | 26,000 | D | ↗ |
| 2025-06-04 | Epstein David M. | Director | A-Award | A | Stock Option (Right to Buy) | 26,000 | 8.58 | 223.1K | 26,000 | D | ↗ |
| 2025-06-04 | Eastling Thomas Wilson | Director | A-Award | A | Stock Option (Right to Buy) | 26,000 | 8.58 | 223.1K | 26,000 | D | ↗ |
| 2025-06-04 | Carmichael Gordon | Director | A-Award | A | Stock Option (Right to Buy) | 26,000 | 8.58 | 223.1K | 26,000 | D | ↗ |
| 2025-05-28 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 558 | 10.07 | 5.6K | 2,806,084 | I | ↗ |
| 2025-05-27 | Zhang Ping | Director | A-Award | A | Stock Option (Right to Buy) | 250,000 | 10.18 | 2.55M | 250,000 | D | ↗ |
| 2025-05-27 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.28 | 20.6K | 2,806,642 | I | ↗ |
| 2025-05-23 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 182 | 10.24 | 1.9K | 2,808,642 | I | ↗ |
| 2025-05-22 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.97 | 21.9K | 2,808,824 | I | ↗ |
| 2025-05-21 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.83 | 21.7K | 2,810,824 | I | ↗ |
| 2025-05-20 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.25 | 22.5K | 2,812,824 | I | ↗ |
| 2025-05-19 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.11 | 22.2K | 2,814,824 | I | ↗ |
| 2025-05-16 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.31 | 22.6K | 2,816,824 | I | ↗ |
| 2025-05-15 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.68 | 21.4K | 2,818,824 | I | ↗ |
| 2025-05-14 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 20 | 11.30 | 226.00 | 2,820,824 | I | ↗ |
| 2025-05-13 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.37 | 22.7K | 2,820,844 | I | ↗ |
| 2025-05-12 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.56 | 21.1K | 2,822,844 | I | ↗ |
| 2025-04-16 | Eastling Thomas Wilson | Director | M-Exempt | D | Stock Option (Right to Buy) | 15,000 | 6.93 | 104.0K | 299,652 | D | ↗ |
| 2025-04-01 | Ye Weiguo | Officer | M-Exempt | D | Stock Option (Right to Buy) | 50,000 | 0.75 | 37.5K | 965,115 | D | ↗ |
| 2025-03-27 | Ye Weiguo | Officer | M-Exempt | D | Stock Option (Right to Buy) | 150,000 | 0.75 | 112.5K | 1,015,115 | D | ↗ |
| 2025-03-26 | Ye Weiguo | Officer | M-Exempt | D | Stock Option (Right to Buy) | 200,000 | 0.75 | 150.0K | 1,165,115 | D | ↗ |
| 2025-03-24 | Ye Weiguo | Officer | M-Exempt | D | Stock Option (Right to Buy) | 300,000 | 0.75 | 225.0K | 1,365,115 | D | ↗ |
| 2025-03-21 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 174 | 10.00 | 1.7K | 2,824,844 | I | ↗ |
| 2025-03-20 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.09 | 20.2K | 2,825,018 | I | ↗ |
| 2025-03-19 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.13 | 20.3K | 2,827,018 | I | ↗ |
| 2025-03-18 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 242 | 10.24 | 2.5K | 2,829,018 | I | ↗ |
| 2025-03-17 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.09 | 24.2K | 2,829,260 | I | ↗ |
| 2025-03-14 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.31 | 24.6K | 2,831,260 | I | ↗ |
| 2025-03-13 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.80 | 23.6K | 2,833,260 | I | ↗ |
| 2025-03-12 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.74 | 23.5K | 2,835,260 | I | ↗ |
| 2025-03-11 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.40 | 22.8K | 2,837,260 | I | ↗ |
| 2025-03-10 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.14 | 20.3K | 2,839,260 | I | ↗ |
| 2025-03-07 | Ye Weiguo | Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 10.32 | 3.10M | 300,000 | D | ↗ |
| 2025-03-07 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 1,906 | 10.13 | 19.3K | 2,841,260 | I | ↗ |
| 2025-03-06 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.80 | 21.6K | 2,843,260 | I | ↗ |
| 2025-03-05 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.98 | 22.0K | 2,845,260 | I | ↗ |
| 2025-03-04 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.86 | 21.7K | 2,847,260 | I | ↗ |
| 2025-03-03 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.23 | 22.5K | 2,849,260 | I | ↗ |
| 2025-02-28 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.41 | 22.8K | 2,851,260 | I | ↗ |
| 2025-02-27 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.33 | 22.7K | 2,853,260 | I | ↗ |
| 2025-02-26 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.63 | 23.3K | 2,855,260 | I | ↗ |
| 2025-02-25 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.37 | 22.7K | 2,857,260 | I | ↗ |
| 2025-02-24 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 187 | 11.52 | 2.2K | 2,859,260 | I | ↗ |
| 2025-02-21 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 182 | 12.60 | 2.3K | 2,861,260 | I | ↗ |
| 2025-02-20 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.40 | 24.8K | 2,863,260 | I | ↗ |
| 2025-02-19 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.29 | 24.6K | 2,865,260 | I | ↗ |
| 2025-02-18 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.49 | 25.0K | 2,867,260 | I | ↗ |
| 2025-02-14 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.94 | 23.9K | 2,869,260 | I | ↗ |
| 2025-02-13 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.69 | 23.4K | 2,871,260 | I | ↗ |
| 2025-02-12 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.49 | 23.0K | 2,873,260 | I | ↗ |
| 2025-02-11 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 1,878 | 11.52 | 21.6K | 2,875,260 | I | ↗ |
| 2025-02-10 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.90 | 23.8K | 2,877,138 | I | ↗ |
| 2025-02-07 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.16 | 24.3K | 2,879,158 | I | ↗ |
| 2025-02-06 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.85 | 25.7K | 2,881,138 | I | ↗ |
| 2025-02-05 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 1,980 | 12.39 | 24.5K | 2,883,158 | I | ↗ |
| 2025-02-04 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.62 | 23.2K | 2,885,138 | I | ↗ |
| 2025-02-03 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.47 | 22.9K | 2,887,138 | I | ↗ |
| 2025-01-31 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.51 | 23.0K | 2,889,138 | I | ↗ |
| 2025-01-30 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.37 | 22.7K | 2,891,138 | I | ↗ |
| 2025-01-29 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.43 | 22.9K | 2,893,138 | I | ↗ |
| 2025-01-28 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.51 | 23.0K | 2,895,138 | I | ↗ |
| 2025-01-27 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.18 | 22.4K | 2,897,138 | I | ↗ |
| 2025-01-24 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.89 | 21.8K | 2,899,138 | I | ↗ |
| 2025-01-23 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.49 | 21.0K | 2,901,138 | I | ↗ |
| 2025-01-22 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.63 | 21.3K | 2,903,138 | I | ↗ |
| 2025-01-21 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.85 | 21.7K | 2,905,138 | I | ↗ |
| 2025-01-17 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.72 | 21.4K | 2,907,138 | I | ↗ |
| 2025-01-16 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.71 | 21.4K | 2,909,138 | I | ↗ |
| 2025-01-15 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.85 | 21.7K | 2,911,138 | I | ↗ |
| 2025-01-14 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.39 | 20.8K | 2,913,138 | I | ↗ |
| 2025-01-13 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 56 | 10.10 | 565.60 | 2,915,138 | I | ↗ |
| 2025-01-10 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 1,057 | 10.02 | 10.6K | 2,915,194 | I | ↗ |
| 2025-01-07 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 1,275 | 10.02 | 12.8K | 2,916,251 | I | ↗ |
| 2025-01-06 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 941 | 10.16 | 9.6K | 2,917,526 | I | ↗ |
| 2025-01-05 | Zhang Ping | Director | A-Award | A | Stock Option (Right to Buy) | 52,000 | 10.79 | 561.1K | 52,000 | D | ↗ |
| 2025-01-03 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 833 | 11.85 | 9.9K | 2,918,467 | I | ↗ |
| 2025-01-02 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.40 | 24.8K | 2,920,467 | I | ↗ |
| 2024-12-31 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.30 | 24.6K | 2,922,467 | I | ↗ |
| 2024-12-30 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.50 | 25.0K | 2,924,467 | I | ↗ |
| 2024-12-27 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.58 | 25.2K | 2,926,467 | I | ↗ |
| 2024-12-26 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 1,644 | 12.62 | 20.7K | 2,928,823 | I | ↗ |
| 2024-12-24 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 11.93 | 23.9K | 2,930,467 | I | ↗ |
| 2024-12-23 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 1,704 | 12.24 | 20.9K | 2,932,763 | I | ↗ |
| 2024-12-20 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.90 | 21.8K | 2,934,467 | I | ↗ |
| 2024-12-19 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 2,000 | 10.82 | 21.6K | 2,936,467 | I | ↗ |
| 2024-12-18 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 1,571 | 11.17 | 17.5K | 2,938,896 | I | ↗ |
| 2024-12-17 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 1,212 | 10.94 | 13.3K | 2,941,255 | I | ↗ |
| 2024-08-14 | Ying Han | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 341,000 | 9.98 | 3.40M | 341,000 | — | ↗ |
| 2024-08-14 | Parry Renate | Director | A-Award | A | Stock Option (Right to Buy) | 52,000 | 9.98 | 519.0K | 52,000 | — | ↗ |
| 2024-08-14 | Nussbaum Rodney L | Director | A-Award | A | Stock Option (Right to Buy) | 52,000 | 9.98 | 519.0K | 52,000 | — | ↗ |
| 2024-08-14 | Ma Songjiang | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 26,000 | 9.98 | 259.5K | 26,000 | — | ↗ |
| 2024-08-14 | Luo Ying | Director | A-Award | A | Stock Option (Right to Buy) | 26,000 | 9.98 | 259.5K | 26,000 | — | ↗ |
| 2024-08-14 | Epstein David M. | Director | A-Award | A | Stock Option (Right to Buy) | 52,000 | 9.98 | 519.0K | 52,000 | — | ↗ |
| 2024-08-14 | Eastling Thomas Wilson | Director | A-Award | A | Stock Option (Right to Buy) | 26,000 | 9.98 | 259.5K | 26,000 | — | ↗ |
| 2024-08-14 | Chen Ruoyu | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 9.98 | 499.0K | 50,000 | — | ↗ |
| 2024-08-14 | Carmichael Gordon | Director | A-Award | A | Stock Option (Right to Buy) | 52,000 | 9.98 | 519.0K | 52,000 | — | ↗ |
| 2024-08-06 | Epstein David M. | Director | A-Award | A | Stock Option (Right to Buy) | 1,866 | 10.79 | 20.1K | 1,866 | — | ↗ |
| 2024-06-28 | USMAN NASSIM | Director | S-Sale | D | Common Stock | 3,452 | 12.00 | 41.4K | 1,636 | — | ↗ |
| 2024-05-01 | USMAN NASSIM | Director | M-Exempt | D | Stock Option (Right to Buy) | 20,000 | 6.93 | 138.6K | 281,652 | — | ↗ |
| 2024-04-01 | USMAN NASSIM | Director | M-Exempt | A | Common Stock | 20,000 | 6.93 | 138.6K | 21,636 | — | ↗ |
| 2024-03-20 | Nussbaum Rodney L | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-15 | USMAN NASSIM | Director | M-Exempt | D | Stock Option (Right to Buy) | 20,000 | 6.93 | 138.6K | 321,652 | — | ↗ |
| 2024-01-03 | Ma Songjiang | Director / Officer | S-Sale | D | Common Stock | 833 | 11.85 | 9.9K | 2,918,467 | I | ↗ |
Executive team
Top executives
EBIT / Employee
19.8K
Shares Outstanding
96.99M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ping Zhang | Interim Chief Executive Officer & Executive Chair | 578.9K | male |
| Weiguo Ye | Chief Operating Officer | 563.4K | male |
| Han Ying | Senior Vice President of Science | 353.3K | — |
| Ruoyu Chen | Chief Financial Officer | 285.6K | female |
| Songjiang Ma | President & Director | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GYRE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
